Hepato-renal protective effects of hydroethanolic extract of Senna alata on enzymatic and nonenzymatic antioxidant systems in streptozotocin induced diabetic rats  by Sugumar, Mohanasundaram et al.
integr med res 5 ( 2 0 1 6 ) 276–283
Available  online  at  www.sciencedirect.com
Integrative  Medicine  Research
j ourna l h o mepage: www.imr- journa l .com
Original Article
Hepato-renal  protective  effects  of hydroethanolic
extract of  Senna  alata  on  enzymatic  and
nonenzymatic antioxidant  systems  in
streptozotocin induced  diabetic  rats
Mohanasundaram Sugumara,∗, D.Victor Arokia Dossb,
P.N.  Prasad Maddisettya
a Research & Development Centre, Bharathiar University, Coimbatore, India
b Department of Biochemistry, PSG College of arts and Science, Coimbatore, India
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 19 January 2016
Received in revised form 2 June 2016
Accepted 22 June 2016
Available online 28 June 2016
Keywords:
antioxidant
hepato-renal
hyperglycemia
oxidative stress
Senna alata
a  b  s  t  r  a  c  t
Background: Oxidative stress induced tissue damage might be the major cause for diabetes
mellitus and its associated complications. The management of such oxidative stress is the
biggest challenge over the decade. The main objective was to analyze the protective effect
of  ethanolic extract of Senna alata L leaves on enzymatic and nonenzymatic antioxidant
systems of hepatic and renal tissues in Streptozotocin-induced diabetes in rats.
Methods: The use of streptozotocin diabetes was induced in the experimental rats and
the  subsequent therapeutic effects of standard drug glibenclamide and Senna alata L were
compared. The levels of plasma insulin, glucose, urea, uric acid, creatinine, vitamin C, vita-
min  E, reduced glutathione, superoxide dismutase, catalase, glutathione peroxidase, and
glutathione-s-tranferase were assayed in control and experimental groups of rats.
Results: These alterations were detected throughout the study duration after the treatment
with Senna alata L and glibenclamide. A signiﬁcant raise followed by the treatment with Senna
alata leaves in vitamin E, catalase, glutathione peroxidase and glutathione-s-tranferase wasobserved. It has been found that notable decline in the levels of vitamin C, reduced glu-
tathione were observed in diabetic rats. The liver and kidney based antioxidant enzyme
activities were signiﬁcantly responsive to the treatment in diabetic rats. Apart from these
antioxidant system, some vital changes were detected in the typical biochemical parame-
protein, urea, uric acid, and creatinine from abnormal into normal inters  such as level of both  the control and induced rats.
∗ Corresponding author. Department of Biotechnology, Karpaga Vinayaga, College of Engineering and Technology, Maduranthagam,
Kanchipuram District, Tamil Nadu-603308, India.
E-mail address: sbmohan2007@gmail.com (M. Sugumar).
http://dx.doi.org/10.1016/j.imr.2016.06.005
pISSN 2213-4220 eISSN 2213-4239/© 2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access article under
the  CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
M. Sugumar et al/Hepato-renal protective effects of Senna alata extract 277
Conclusion: From the above said observations, it was very clear that, Senna alata has helped
to  manage the oxidative tension in diabetic rats, which in turn may greatly support the
hypoglycaemic potency of Senna alata L.
©  2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license
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s.  Introduction
edicinal plants are the only promising source for developing
hallenging drugs for many  diseases in this century. Though
ore  than a few hundred medicinal plants are widely used as
herapeutic sources for diabetes, only a very few of them have
een well studied scientiﬁcally. Either as preventive or thera-
eutic medicine, a lot of phytochemicals have been extracted
uccessfully from medicinal plants for a wide range of dis-
ases such as cancer, heart disease, diabetes, and high blood
ressure. It is expected that the diabetic population of this
niverse may reach 439 million by 2030. India, the “diabetes
apital of the world” is having more  diabetic patients and
hina and America are the subsequent followers.1 In modern
ays, to manage diabetes, insulin injection is the most pre-
erred one in case of Type 1 and oral hypoglycemic drugs are
he choice for Type 2 diabetes with certain limitations. Gen-
rally, it was is well understood by elevated sugar level with
mbalanced metabolic conditions followed by chronic organ
ailures. Few bioactive molecules were found successful and
roven in protection against diabetes.2 In recent times, the
igniﬁcance of antioxidants has increasingly received more
ttention as an important factor in the biochemical manage-
ent of oxidative stress. Any substance which can inhibit or
elay the undeserved peroxidation and prevent the oxidative
amage to a particular cell or molecule is said to be an antiox-
dant. In general, tissue or cell damage is mainly caused by
he elevated generation of free radicals. In general, free radi-
als are having the power to damage or destroy the major
iochemical components of the tissues such as lipids, car-
ohydrates, proteins, and DNA. Antioxidant molecules have
he tendency of removing these free radicals thereby pre-
enting the cell from the damage. This removal mechanism
as done by transferring one hydrogen atom to the reactive
adical intermediate. Huge numbers of food stuffs have been
etected to contain such antioxidants in the form of bioactive
ompounds.3 Antidiabetic agents of naturals products, used
oth in recent and folklore medicine, are recommended by
he World Health Organization (WHO). Alternative therapies
ave to be identiﬁed in order to manage and prevent diabetic
omplications. Therefore, medicinal plants screening towards
dentifying a new potent antidiabetic therapy is increasing day
y day among scientiﬁc researchers. The importance of oxida-
ive stress in diabetes has been studied extensively in recent
imes and it has been well understood that through many  bio-
hemical events excess of free radicals will be liberated during
yperglycemia.4 Degeneration or extensive damage caused by
treptozotocin in pancreatic beta cells is the main mechanism
ehind in the induction of Type 2 diabetes in experimental
ats. It has been proven already that this degeneration is pos-
ible only when excess release of reactive oxygen species.5(http://creativecommons.org/licenses/by-nc-nd/4.0/).
The damage caused by the streptozotocin will usually result
in hypoinsulinemia and poor glucose utilization by the cells.
Liver, the major organ for glucose metabolism will suffer a lot
due to the lack of insulin. This condition may further extend
to damage the cellular membranes of liver cells due to the
availability of huge free radicals.6 Once the cells are dam-
aged, it will affect the major cellular functional constituents
such as enzymes, antioxidant systems and may result in the
development of chronic illness. Hence, in most of the treat-
ment ideas in diabetes, regeneration of the damaged cells and
increased glucose utilization by the cells are considered to be
the major breakthroughs. Many clinical ﬁndings have proven
the usefulness of medicinal plants and their metabolites in
the changeover of oxidative stress in diabetic individuals.7
Due to the undesirable side effects of current antidiabetic
agents, there is a demand and expectation for a safe antidi-
abetic drug discovery system especially focusing on natural
plant sources, which can manage oxidative stress and diabetes
mellitus without any other side effects.8 While considering
the above ﬁndings, it should be taken in consideration that
antioxidants may show a useful pharmacological approach in
controlling the diabetes.
The present study was aimed to examine the effect of
Senna alata L on the enzymatic and nonenzymatic antioxidant
defense systems in both liver and renal tissues of streptozo-
tocin induced diabetic rats to understand the oxidative stress
management potency.
2.  Methods
2.1.  Animals
Male albino Wistar rats (250–300 g) used in this study were
housed in polypropylene cages of standard size and main-
tained under standard environmental conditions (14 hour
dark /10 hour light cycles; temperature 25 ± 2 ◦C; 35–60%
humidity, air ventilation) and were fed with standard pel-
let diet (M/s. Hindustan Lever Ltd., Mumbai, India) and fresh
water ad libitum. The animals were adapted to the environ-
ment for 2 weeks prior to study. Animals were fasted overnight
prior to the experimental schedule with free access to water
ad libitum. The experiments were conducted according to the
ethical norms approved by Ministry of Social Justices and
Empowerment, Government of India and Institutional Animal
Ethics Committee Guidelines.
2.2.  Drugs  and  chemicals
Streptozotocin was procured from Sigma Chemical Co., St.
Louis, MO, USA. All other chemicals used were of analytical
grade.
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2.3.  Plant  material
Fresh leaves of Senna alata were collected from in and around
the regions of Thirukkalukundram taluk, Kanchipuram Dis-
trict, Tamil Nadu, India. The plant was authenticated by the
regional Centre, Botanical Survey of India, Coimbatore.
2.4.  Plant  extract  preparation
Fresh leaves of Senna alata L were collected from the vil-
lage near Thirukkalukundram. The leaves of the plant were
washed under the tap water and shade dried for 8–10 days.
Then, the leaves of the plant was made into coarse powder
using a mechanical grinder. Ten g of powdered plant leaves
were taken and 100 mL of 50% ethanol was added and kept
overnight in the shaker. The extract was ﬁltered and the sol-
vent was added again and kept in the shaker for next 7 hours.
In this way the plant extract was collected and stored in the
air tight container for further use.
2.5.  Experimental  induction  of  diabetes  mellitus
Streptozotozin-induced diabetes mellitus was induced in
overnight fasted wistar albino rats by a single intraperitoneal
injection of streptozotozin (50 mg/kg of body weight.) dis-
solved in citrate buffer (0.01 M,  pH 4.5). In order to stave off
the hypoglycaemic shock during the 1st day after the strep-
tozotozin administration, diabetic rats were given 5% glucose
solution orally. It was noted that streptozotozin had induced
hyperglycemia in experimental rats within 48 hours.9 Dia-
betes was conﬁrmed by the determining the fasting blood
glucose concentration using glucose oxidase–peroxidase reac-
tive strips and a glucometer after 48 hours of administration
of streptozotozin. Animals observed with blood glucose levels
above 250 mg/dL were considered diabetic and were selected
for the study.
2.6.  Experimental  design
For antidiabetic evaluation, a total of 24 rats (18 diabetic sur-
viving rats and 6 normal rats) were used. Animals were divided
into four groups of six animals each and were treated as given
below: (1) Group 1: normoglycemic control animals; (2) Group
2: streptozotozin (STZ)-induced diabetic animals; (3) Group 3:
STZ induced animals followed by the treatment with gliben-
clamide (600 g/kg bw); and (4) Group 4: STZ induced animals
followed by the treatment with the ethanolic extract of Senna
alata (400 mg/kg bw).
Groups 3 and 4 animals were orally administered with the
standard drug glibenclamide (600 g/kg bw) and the sample
extract (400 mg/kg bw) once daily for 30 days. Day 3 of induc-
tion was designated as Day 1 for extract administration in
diabetic rats. Blood samples were drawn by snipping marginal
tail at weekly intervals during the study period. The levels of
blood glucose and body weight were monitored periodically
using glucometer (glucose oxidase method).
The animals were anesthetized with ketamine (80 mg/kg of
body weight through intraperitoneally) and sacriﬁced by cer-
vical decapitation. Serum and plasma were separated from
the collected blood. The important organs such as liver and
kidney were properly excised and preserved. One g of it wasIntegr Med Res ( 2 0 1 6 ) 276–283
homogenized in 0.25 M Tris HCl buffer (pH 7.5) and centrifuged
at 10,000 rpm for 20 minutes at 4◦C. The clear supernatant
obtained was used for measuring the antioxidant markers.
2.7.  Analysis  of  common  biochemical  factors
The major and common biochemical factors includes
plasma glucose,10 insulin,11 protein,12 urea,13 uric acid,14 and
creatinine15,16 were analyzed by the speciﬁed proven methods
and the signiﬁcance in changes from abnormal to normal
level was compared to understand therapeutic potency of
Senna alata (L).
2.8.  Measurement  of  nonenzymatic  antioxidants
The changes in the levels of the most important nonenzy-
matic antioxidants includes vitamin C,17 vitamin E,18 and
glutathione (GSH) 19 were detected by speciﬁed proven meth-
ods and the signiﬁcance was compared.
2.9.  Detection  of  enzymatic  antioxidants
The signiﬁcant changes in the levels of the enzymatic
antioxidants includes super oxide dismutase,20 catalase,21
and glutathione peroxidase22 and glutathione-s-transferase23
were detected by the speciﬁed proven methods and statisti-
cally compared.
2.10.  Statistical  analysis
The results we obtained in our study were analyzed by one
way analysis of variance (ANOVA) followed by least signiﬁ-
cant difference (LSD) test and it was considered statistically
signiﬁcant when p < 0.05. All the results were expressed as
mean ± standard deviation (SD) for six animals in each group.
3.  Results
3.1.  Effect  on  total  protein  and  albumin
We have observed a signiﬁcant (p < 0.05) decline in the level of
total protein and albumin in diabetic rats (Group 2) than nor-
mal  control rats (Group 1). Administration of glibenclamide
(Group 3) and Senna alata L extract (Group 4) notably (p < 0.05)
raised into normal level (Table 1). It shows that the plant
extract has some positive effect which has favored the normal
level of protein synthesis followed by the treatment.
3.2.  Effect  on  urea,  uric  acid,  and  creatinine  levels
We have found a signiﬁcant (p < 0.05) raise in the level of urea,
uric acid and creatinine were observed in diabetic rats (Group
2) than normal control rats (Group 1). Administration of gliben-
clamide (Group 3) and Senna alata L extract (Group 4) notably
(p < 0.05) decreased the urea, uric acid, and creatinine into nor-
mal  level (Table 2). It shows that the plant extract has showed
its inhibitory effect on unnecessary degradation of protein
that may be released due to cell damage caused by free radi-
cals.
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Table 1 – Effect of Senna alata extract on serum total protein and albumin in experimental rats
Group Method of treatment Total protein (mg/dL) Albumin (mg/dL)
1 Normal control 9.69 ± 0.48 5.66 ± 0.45
2 Diabetic control (STZ induced) 4.36 ± 0.42* 4.47 ± 0.27*
3 STZ + glibenclamide Treated 8.11 ± 0.45* 5.12 ± 0.33*
4 STZ + Senna alata treated 6.07 ± 0.48* 4.81 ± 0.31*
Values are given as mean ± SD for groups of six rats in each.
∗ Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were compared with Group 2.
SD, standard deviation; STZ, streptozotozin.
Table 2 – Effect of Senna alata extract on urea and uric acid in experimental rats
Group Method of treatment Urea (mg/dL) Uric acid (mg/dL) Creatinine (mg/dL)
1 Normal control 30.22 ± 1.48 1.36 ± 0.08 0.88 ± 0.09
2 Diabetic control (STZ induced) 53.77 ± 6.38 * 2.02 ± 0.11 * 1.73 ± 0.16 *
3 STZ + glibenclamide Treated 44.88 ± 3.73 * 1.54 ± 0.11 * 1.20 ± 0.06 *
4 STZ + Senna alata treated 45.64 ± 2.78 * 1.60 ± 0.08 * 1.18 ± 0.07 *
Values are given as mean ± SD for groups of six rats in each.
∗ Values are statistically signiﬁcant when p < 0.05.
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Fig. 1 – Effect of Senna alata extract on plasma insulin level
in experimental rats.
Values are given as mean ± SD for groups of six rats in
each.
* Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were
compared with Group 2.
SD, standard deviation.Group 2 was compared with Group 1; Groups 3 and 4 were compare
SD, standard deviation; STZ, streptozotozin.
.3.  Effect  on  plasma  glucose  and  insulin
e  have noticed a considerable (p < 0.05) elevation in blood
lucose (Table 3) and the associated decline in insulin (Group
) in diabetic rats than control rats (Group 1). Treatment with
libenclamide (Group 3) and Senna alata (Group 4) notably
p < 0.05) reduced the blood glucose and increased insulin
Fig. 1) to normal levels. Similarly, the decline in the body
eight due to diabetes was rectiﬁed notably (p < 0.05) in all
he induced rats (Table 4).
.4.  Levels  of  vitamin  C,  vitamin  E,  and  GSH
 signiﬁcant decrease (p < 0.05) in the level of natural antiox-
dants such as vitamin C, vitamin E, and GSH were observed
n diabetic rats when compared with control rats. This decline
ight be the major fact for cell damage associated with dia-
etes as a result of undesirable peroxidation processes and
ubsequent free radicals generation. Group 3 and Group 4 rats
ends to bring these levels into normal (Table 5). It was clearly
bserved in the experimental rats.
A considerable decline observed in the concentration of
educed glutathione in liver and renal tissues of induced
Table 3 – Effect of Senna alata extract on plasma glucose level in experimental rats
Group Method of treatment D 0 D 3 D 10 D 20 D 30
1 Normal control 75.17 ± 1.00 74.17 ± 0.79 77.33 ± 0.64 79.83 ± 0.59 78.33 ± 1.26
2 Diabetic control (STZ induced) 76.17 ± 0.28* 359.17 ± 1.21* 391.5 ± 1.30* 411.83 ± 1.27* 452 ± 1.41*
3 STZ + glibenclamide treated 69.5 ± 0.57* 408 ± 0.83* 389.83 ± 2.46* 254.33 ± 1.34* 172 ± 1.02*
4 STZ + Senna alata treated 83.67 ± 9.77 * 378.53 ± 2.85 * 399.12 ± 2.01 * 269.08 ± 2.35 * 180.65 ± 3.32 *
Values are given as mean ± SD for groups of six rats in each.
∗ Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were compared with Group 2.
SD, standard deviation; STZ, streptozotozin.
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Fig. 2 – Effect of Senna alata extract on SOD (Superoxide
dismutase) level in liver and renal tissues of experimental
rats.
Values are given as mean ± SD for groups of six rats in
each.
* Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were280  
rats was raised into normal level after the treatment
(Table 5).
3.5.  Effects  on  enzymatic  antioxidants  of  liver  SOD,
CAT, GPx  and  GST
Signiﬁcant (p < 0.05) reductions were observed in the activi-
ties of SOD (Superoxide Dismutase) (Fig. 2), CAT (Catalase)
(Fig. 3), GPx (Glutathione Peroxidase) (Fig. 4), and GST (Glu-
tathione S Transferase) (Fig. 5) in liver and renal tissues of
all the experimental groups of rats. After administration of
Senna alata extract and glibenclamide, the activities of these
enzymes were raised to near normal in diabetic rats which
clearly showed the antioxidant potency of our plant extract.
This might be the major reason behind the oxidative stress
management in diabetic rats in this study.
4.  Discussion
Universally, diabetes is a complicated biochemical challenge
affecting a huge number of human individuals. In current ther-
apeutic choices, there are so many  side effects and secondary
failures have been found. Still, there is a gap in designing
a promising way for the treatment of diabetes but, through
many studies it has been proven already that the plant king-
dom is a rich source of bioactive compounds with potency
towards the therapy for diabetes.24 We have examined the
potency of Senna alata L by noticing its inﬂuences on the
Table 4 – Effect of Senna alata extract on level of body weight ga
Group Method of treatment D 0 (g) D
(g
1 Normal control 182.35 ± 4.51 182.83
2 Diabetic control (STZ induced) 197.85 ± 2.35 * 191.17
3 STZ + glibenclamide treated 197.5 ± 1.38 * 195.17
4 STZ + Senna alata treated 193.97 ± 2.04 * 189.58
Values are given as mean ± SD for groups of six rats in each.
∗ Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were compared wit
SD, standard deviation; STZ, streptozotozin.
Table 5 – Effects of Senna alata extract on nonenzymatic antiox
Group Method of
treatment
Vitamin C
(g/mg of protein)
Liver Kidney 
1 Normal control 88.11 ± 4.00 103.79 ± 6.32 2.
2 Diabetic control
(STZ induced)
72.75 ± 5.05 * 84.79 ± 5.72 * 1.
3 STZ + glibenclamide
treated
76.9 ± 3.23 * 98.57 ± 9.56 * 2.
4 STZ + Senna alata
treated
78.13 ± 6.90 * 93.6 ± 5.14 * 2.
Values are given as mean ± SD for groups of six rats in each.
∗ Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were compared wit
SD, standard deviation; STZ, streptozotozin.compared with Group 2.
SD, standard deviation.
activities of key enzymes and other factors involved in the
antioxidant defense systems of control and induced rats.25
In diabetes mellitus the declined insulin or its efﬁciency
will result in impaired carbohydrate metabolism. In this study,
in in experimental rats
 3
)
D  10
(g)
D  20
(g)
D  30
(g)
 ± 3.43 185.0 ± 5.48 191.83 ± 4.12 203.71 ± 3.09
 ± 3.97 * 185.5 ± 1.94 * 174.83 ± 2.29 * 166.3 ± 2.31 *
 ± 3.71* 191.17 ± 4.79 * 190.05 ± 1.19 * 197.17 ± 1.67 *
 ± 0.97 * 188.22 ± 0.77 * 190.21 ± 1.02 * 192.35 ± 1.57 *
h Group 2.
idants of liver and kidney in experimental rats
Vitamin E
(g/mg of protein)
GSH
(g/gm of Tissue)
Liver Kidney Liver Kidney
53 ± 0.09 2.42 ± 0.14 26.47 ± 3.99 24.7 2 ± 2.20
83 ± 0.21 * 1.8 ± 0.16 * 14.73 ± 1.08 * 19.23 ± 0.58 *
6 ± 0.17 * 2.46 ± 0.04 * 23.17 ± 1.72 * 20.56 ± 0.87 *
47 ± 0.06 * 2.31 ± 0.11 * 23.15 ± 1.04 * 20.62 ± 1.15 *
h Group 2.
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Fig. 3 – Effect of Senna alata extract on catalase in liver and
renal tissues of experimental rats.
Values are given as mean ± SD for groups of six rats in
each.
* Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were
compared with Group 2.
SD, standard deviation.
Fig. 4 – Effect of Senna alata extract on GPx (Glutathione
peroxidase) level in liver and renal tissues of experimental
rats.
Values are given as mean ± SD for groups of six rats in
each.
* Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were
compared with Group 2.
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Fig. 5 – Effect of Senna alata extract on GST level in liver and
renal tissues of experimental rats.
Values are given as mean ± SD for groups of six rats in
each.
* Values are statistically signiﬁcant when p < 0.05.
Group 2 was compared with Group 1; Groups 3 and 4 were
compared with Group 2.D, standard deviation.
 noticeable (p < 0.05) decline in blood glucose and rise in
lasma insulin levels were observed in rats treated with our
lant extract. Senna alata might trigger the beta cells of pan-
reas to discharge more  insulin which is essentially needed to
ower the elevated blood glucose. Senna alata tends to lower
lood glucose because of the release of insulin by the rede-
eloped beta cells of pancreas. Otherwise, it should have
nhibitory effects on ATP sensitive K+ channels such as gliben-
lamide so that it has released insulin from redeveloped
eta-cells and regulates blood glucose level26 in STZ-diabeticGSH, glutathione; SD, standard deviation.
rats. Hence, Senna alata was proven to be a notable option for
blood glucose maintenance. Studies also suggests that subse-
quent insulin level is must for carbohydrate metabolism.27
It was clearly observable that there was signiﬁcant (p < 0.05)
decrease in the body weight in induced rats as a result of
abnormal carbohydrate metabolism.28 In an earlier study it
was reported that a great reduction in protein synthesis was
observed in almost all the tissues due to insufﬁcient ATP and
insulin.29
After treatment, in Groups 3 and 4, there was an
improvement in body weight of rats due to improvement in
hyperglycemic control. Due to the poor synthesis of protein
and high degradation protein, the levels of urea, uric acid, and
creatinine increased in diabetic rats. However, after successful
administration with Senna alata, it had been greatly reduced to
its normal level which clearly indicates that, protein degrada-
tion has been reduced signiﬁcantly because of the treatment
with Senna alata. In diabetes, tissue damage is an unavoidable
issue as result of excessive generation of free radicals due to
lack of insulin. This may further raise lipid peroxidation pro-
cesses in the biological systems30,31 and similar results were
detected in our present study.
Normal GSH is needed to preserve the structural and func-
tional integrity of cells. The distinctive reduction in GSH level
of liver and kidney tissues in diabetic rats and its subsequent
rise up to normal level in Senna alata extract administration
shows that the protection was offered by Senna alata in battling
oxidative stress which is comparable with previous studies.32
Reduction in SOD, GPx, GST, and CAT found in induced rats
shows the possibility of free radical induced damage. As we
know very well, whenever we fail to maintain the ratio of
antioxidants and free radicals normally, there will be a deﬁnite
deregulation of cellular damage and activities.33 An antioxi-
dant drug can alleviate this dysfunction issues. The rise in the
rnatural products. In: Compendium of bioactive natural
products, M/S. Studium Press. LLC, USA, 2009;vol. 2, p. 1-30.
9.  Siddique O, Sun Y, Lin JC, Chien YW. Facilitated transdermal282  
activities of the antioxidant enzymes in Senna alata adminis-
tered rats showed the potency of the plant extract in managing
oxidative stress in diabetic rats.
It has been well proven in many  studies that through a
diet with huge antioxidants, unnecessary peroxidation pro-
cess can be avoided.34 Treatment of Senna alata to induced rats
preserved the antioxidant defense enzymes into normal con-
dition which might be the result of antioxidant properties of
the plant.
SOD, the key enzyme of antioxidant system of tissues pre-
vents reactive oxygen species by catalyzing the dismutation of
superoxide to H2O235 whereas catalase decays hydroxyl radi-
cals and is widely dispersed in all the tissues especially in the
RBC (Red Blood Cells) and liver.36 Reduction in these enzyme
activity outcomes in several harmful effects due to gathering
of superoxide and hydroxyl radicals. In this attempt, a decline
in the CAT activity has been noticed. In experimental rats, the
unrestrained release of hydrogen peroxide owing to the auto-
oxidation of glucose and lipid oxidation led to notable decline
in the CAT activity.37
Glutathione peroxidase splits hydrogen peroxide into
water and molecular oxygen through the oxidation of reduced
glutathione.38 It is a vital preventive response during huge
oxidative stress. Due to ROS (Reactive Oxygen Species) medi-
ated inactivation and glycation, there will be decline in
glutathione activity in diabetes.39 The decreased role of GPx
could be observable in low content of glutathione in induced
rats. Senna alata has elevated them by inhibiting lipid peroxida-
tion signiﬁcantly. Therefore, any compound with antioxidant
potency can be tried against oxidative stress and which may
be also be effective in STZ induced diabetes.
Another important enzyme of this antioxidant system GST
which is decreased in diabetic rats and subsequent raise after
the treatment with Senna alata is also another supporting evi-
dence for the antioxidant potency of Senna alata. In the result
of a previous study40 it was suggested that the reduction of
GSH level also may reduce GST enzyme. In our study the enzy-
matic antioxidant activities such as SOD, CAT, GPx, and GST
decreased in induced rats has been raised into normal level
after successful administration with our plant extract.
It has already been demonstrated41 that the decreased
antioxidants synthesis can be seen during increased oxygen
metabolites. In this perspective, it was also reported a dimin-
ished activity of enzymatic antioxidants in diabetic rats.42
It has been proven that diabetics have low levels of nonen-
zymatic antioxidants and their supplementation may help to
overcome diabetes. In general, these antioxidants are required
to inhibit the peroxidation of membrane lipids,43 GSH, an
antioxidant needed for cellular protection, such as detoxiﬁ-
cation of ROS, and removal of toxins.44 Depletion of tissue
GSH levels conﬁrmed among diabetic rats clearly states the
elevated utilization by the hepatic cells which might be the
outcome of least synthesis or higher degradation of GSH.45 In
earlier published reports, it was proven that the GSH concen-
tration decreases in the diabetic rats.46 It has been observed
that treatment with Senna alata and glibenclamide signiﬁ-
cantly raised the vitamin C, vitamin E, and GSH levels in
diabetic rats.
In consideration with the results we obtained and earlier
study observations, it was clearly indicated that Senna alata LIntegr Med Res ( 2 0 1 6 ) 276–283
has the tendency to prevent the liver and renal tissues from
the damage caused by the oxidative stress during diabetes in
STZ induced experimental rats. It has good impact on both
the enzymatic (SOD, CAT, GPx, and GST) and nonenzymatic
antioxidant (vitamin C, vitamin E, and GSH). It has greatly
inﬂuenced the rate of protein degradation by reducing its end
products (urea, uric acid, and creatinine) elimination. On the
whole, Senna alata L has much hope for its hypoglycemic prop-
erty which had been proven in its plasma glucose lowering
effect, body weight gain, and plasma insulin level improve-
ments. Therefore, further studies are necessary to elucidate
the exact mechanism by which Senna alata L exhibits its ther-
apeutic effects.
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